Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 1, 2017, James Bayardelle resigned from his position as Chief Executive Officer of Nexus Enterprise Solutions, Inc. (the "Company"). There were no disagreements between the Company and James Bayardelle.
On September 1, 2017, Christopher Ashe, was appointed as the Company's Chief Executive Officer. Prior to his appointment,
Christopher Ashe led the product management team at Contact At Once, LLC, a $30M business unit of Live Person, Inc., a global leader in enterprise and vertical market mobile messaging solutions) for six years ending August 18, 2017. Prior to Contact At Once, LLC, Mr. Ashe held product and senior leadership positions in a number of technology companies serving a variety of markets including digital video, financial services, monitored security, medical devices, beverages, telecommunications and toys. Mr. Ashe studied Math and Physics at University of Georgia.
In connection with his appointment, the Company and Devgen, LLC, an entity owned by Mr. Ashe, entered into an Independent Contractor Agreement dated September 1, 2017 (the "Agreement"). Pursuant to the Agreement, Mr. Ashe will receive a monthly cash fee of $10,000, as well as a variable fee of 5% of total gross profit under $100,000, 4% of total gross profit over $100,000 and 5% of gross profits from customers obtained by Mr. Ashe. Pursuant to the Agreement, for a period of one year from September 1, 2017 (the "Effective Date"), Mr. Ashe will be paid a minimum of $12,000 per month (the "Minimum Fee"), which shall include the monthly cash fee and the variable fee. Mr. Ashe has also agreed that for the first three months from the Effective Date, $2,000 of the Minimum Fee shall be paid as a promissory note to be repaid in equal installments of $500 over a twelve month period, beginning in the fourth month from the Effective Date. In addition, Mr. Ashe will be issued 1,200,000 shares of restricted common stock to be issued as 200,000 shares upon the Effective Date, with the remaining 1,000,000 shares to be issued in equal quarterly installments from January 10, 2018 through October 1, 2020.
The foregoing description of the Agreement is qualified in its entirety by reference to the full text of the Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.